NCT00994799 Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema Status UNKNOWN Phase N/A
NCT00989989 Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT00967213 Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration Status COMPLETED Phase PHASE3
NCT00955630 Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome Status UNKNOWN Phase PHASE1/PHASE2
NCT00942864 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Status COMPLETED Phase PHASE3
NCT00892398 Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab Status COMPLETED Phase NA
NCT00891735 A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR) Status COMPLETED Phase PHASE3
NCT00885794 Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME) Status UNKNOWN Phase PHASE2/PHASE3
NCT00857259 The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration Status TERMINATED Phase PHASE2
NCT00846625 Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids Status WITHDRAWN Phase PHASE2
NCT00831350 Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Status COMPLETED Phase PHASE2
NCT00826618 Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema Status COMPLETED Phase PHASE1
NCT00813891 Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration Status UNKNOWN Phase PHASE4
NCT00793923 A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD Status COMPLETED Phase PHASE1/PHASE2
NCT00775411 Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) Status COMPLETED Phase PHASE2
NCT00769145 Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery Status COMPLETED Phase PHASE1